SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Keiichi Nakahara, Mitsuharu Ueda, Kazumichi Yamada, Tatsuya Koide, Genshin Yoshimochi, Manabu Funayama, Jeong-ho Kim, Shiori Yamakawa, Akira Mori, Yohei Misumi, Eiichiro Uyama, Nobutaka Hattori, Yukio Ando, Juvenile-onset parkinsonism with digenic parkin and PINK1 mutations treated with subthalamic nucleus stimulation at 45years after disease onset, Journal of the Neurological Sciences, 2014, 345, 1-2, 276

    CrossRef

  2. 2
    Hee Jin Kim, Ji Young Yun, Young-Eun Kim, Jee-Young Lee, Han-Joon Kim, Ji-Young Kim, Sung Sup Park, Sun Ha Paek, Beom S. Jeon, Parkin mutation and deep brain stimulation outcome, Journal of Clinical Neuroscience, 2014, 21, 1, 107

    CrossRef

  3. 3
    Lior Greenbaum, Simon D. Israeli-Korn, Oren S. Cohen, Sandra Elincx-Benizri, Gilad Yahalom, Evgenia Kozlova, Hanna Strauss, Noa Molshatzki, Rivka Inzelberg, Roberto Spiegelmann, Zvi Israel, Sharon Hassin-Baer, The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 11, 1053

    CrossRef

  4. 4
    Amanda J. Thompson, Sonja W. Scholz, Andrew B. Singleton, Angela Hardwick, Nikolaus R. McFarland, Michael S. Okun, Variability in clinical phenotypes of heterozygous and homozygous cases ofParkin-related Parkinson's disease, International Journal of Neuroscience, 2013, 123, 12, 847

    CrossRef

  5. 5
    Tohru Kitada, Julianna J. Tomlinson, Hei Sio Ao, David A. Grimes, Michael G. Schlossmacher, Considerations Regarding the Etiology and Future Treatment of Autosomal Recessive Versus Idiopathic Parkinson Disease, Current Treatment Options in Neurology, 2012, 14, 3, 230

    CrossRef

  6. 6
    Alfonso Fasano, Günther Deuschl, Patients and DBS targets: Is there any rationale for selecting them?, Basal Ganglia, 2012, 2, 4, 211

    CrossRef

  7. 7
    Matthew F. DiFrancesco, Casey H. Halpern, Howard H. Hurtig, Gordon H. Baltuch, Gregory G. Heuer, Pediatric indications for deep brain stimulation, Child's Nervous System, 2012, 28, 10, 1701

    CrossRef

  8. 8
    Angelo Antonini, Manuela Pilleri, Angelo Padoan, Andrea Landi, Salvatore Ferla, Roberta Biundo, Domenico D’Avella, Successful subthalamic stimulation in genetic Parkinson’s disease caused by duplication of the α-synuclein gene, Journal of Neurology, 2012, 259, 1, 165

    CrossRef

  9. 9
    Alfonso Fasano, Antonio Daniele, Alberto Albanese, Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation, The Lancet Neurology, 2012, 11, 5, 429

    CrossRef

  10. 10
    Sorin Breit, T. Wächter, D. Schmid-Bielenberg, D. Weiss, P. Leitner, T. Nägele, D. Freudenstein, T. Gasser, R. Krüger, Effective long-term subthalamic stimulation in PARK8 positive Parkinson’s disease, Journal of Neurology, 2010, 257, 7, 1205

    CrossRef

  11. 11
    Georgia Xiromerisiou, Efthimios Dardiotis, Vaïa Tsimourtou, Persa Maria Kountra, Konstantinos N. Paterakis, Eftychia Z. Kapsalaki, Kostas N. Fountas, Georgios M. Hadjigeorgiou, Genetic basis of Parkinson disease, Neurosurgical FOCUS, 2010, 28, 1, E7

    CrossRef

  12. 12
    Teri R. Thomsen, Robert L. Rodnitzky, Juvenile Parkinsonism, CNS Drugs, 2010, 24, 6, 467

    CrossRef

  13. 13
    Romain Lefaucheur, Stéphane Derrey, Lucie Guyant-Maréchal, Nathalie Chastan, David Maltête, Whatever the disease duration, stimulation of the subthalamic nucleus improves Parkin disease, Parkinsonism & Related Disorders, 2010, 16, 7, 482

    CrossRef